Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AnTIC study of once-daily antibiotic prophylaxis for intermittent bladder catheterisation
2013-002556-32Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Aug 2013
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of trimethoprim, nitrofurantoin and cefalexin in urinary tract infection (UTI) (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Primary endpoint: Incidence of symptomatic antibiotic-treated urinary tract infection over 12 months. Started Aug 2013; status: completed.
02
Drugs
trimethoprimnitrofurantoincefalexin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2013-002556-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002556-32.